Lexology June 27, 2024
Ropes & Gray LLP

Click here to listen to the audio

On this episode of Ropes & Gray’s podcast series, Non-binding Guidance, counsel Steve Sencer moderates a discussion on how FDA regulatory issues may impact academic medical centers (AMCs), health systems, and universities/research institutions. Joined by partner David Peloquin, and counsel Sarah Blankstein and Beth Weinman, the episode explores the complexities of FDA regulation, the potential risks, and the best practices to mitigate them. The discussion also highlights the challenges and implications of using digital tools in research studies.

Transcript:

Steve Sencer: Welcome to Non-binding Guidance, a podcast series from Ropes & Gray focused on current trends in FDA regulations and enforcement. My name is Steve Sencer, and I’m counsel in Ropes & Gray’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Health System / Hospital, Provider, Trends
Related Articles:
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
STAT+: FDA approves Eli Lilly’s early Alzheimer’s treatment
Supreme Court to weigh whether the FDA was heavy-handed with flavored e-cigarette products
STAT+: How controversial was the decision by FDA’s Peter Marks to approve Sarepta’s gene therapy? Check its footnotes
FDA Finds Infectious H5N1 Bird Flu Virus In 14% Of Raw Milk Samples

Share This Article